Inventor · disambiguated record

John Robert Springer

Also filed as: SPRINGER JOHN · SPRINGER JOHN R · SPRINGER JOHN ROBERT

13 granted patents·8 pending applications·72 citations·filing 1981–2025

89Inventor score

Technology areasA61P C07D A47L A61K

Files withACLARIS THERAPEUTICS INC11 PFIZER4 CONFLUENCE LIFE SCIENCES INC3 NU CO IND INC1 PHARMACIA CORP1

Top patents by PatentIndex Score

21 records

0194US9695200B2Heterocyclic ITK inhibitors for treating inflammation and cancerCONFLUENCE LIFE SCIENCES INC·Filed 2016·Granted Jul 4, 2017·19 cites·7 claims
0289US11767309B2Methods of synthesizing substituted pyridinone-pyridinyl compoundsACLARIS THERAPEUTICS INC·Filed 2021·Granted Sep 26, 2023·1 cites·36 claims
0388US11844801B2Oral compositions of MK2 pathway inhibitor for treatment of immune conditionsACLARIS THERAPEUTICS INC·Filed 2021·Granted Dec 19, 2023·2 cites·64 claims
0487US7259266B2Benzopyran compounds useful for treating inflammatory conditionsPHARMACIA CORP·Filed 2004·Granted Aug 21, 2007·38 cites·1 claims
0581US10266513B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2017·Granted Apr 23, 2019·2 cites·6 claims
0681US9505765B24-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatmentCONFLUENCE LIFE SCIENCES INC·Filed 2013·Granted Nov 29, 2016·3 cites·24 claims
0781US9499551B2Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseasesCONFLUENCE LIFE SCIENCES INC·Filed 2015·Granted Nov 22, 2016·4 cites·10 claims
0880US12384757B2Methods of synthesizing substituted pyridinone-pyridinyl compoundsACLARIS THERAPEUTICS INC·Filed 2023·Granted Aug 12, 2025·0 cites·10 claims
0980US12370195B2Oral compositions of MK2 pathway inhibitor for treatment of immune conditionsACLARIS THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·0 cites·24 claims
1076US2025387393A1Oral compositions of mk2 pathway inhibitor for treatment of immune conditionsACLARIS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
1168US2021002251A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2020·Application pending·0 cites
1266US10815213B2Bruton's tyrosine kinase inhibitorsPFIZER·Filed 2019·Granted Oct 27, 2020·0 cites·4 claims
1363US2023286950A1Methods of synthesizing deuterated substituted pyridinone-pyridinyl compoundsACLARIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
1459US2015291554A1Bruton's Tyrosine Kinase InhibitorsPFIZER·Filed 2013·Application pending·0 cites
1559US2019352300A1Pyrrolopyrimidine itk inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
1658US10316038B2Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2019·0 cites·27 claims
1757US2019106439A1Heterocyclic itk inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
1856US2023365555A1Crystalline polymorph form a of a jak inhibitorand methods for its preparationACLARIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
1954US10150783B2Heterocyclic ITK inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·0 cites·21 claims
2043US2005148627A1Benzopyran compounds for use in the treatment and prevention of inflammation related conditionsFiled 2004·Application pending·0 cites
2124US4365378ACarpet and fabric cleaning machineNU CO IND INC·Filed 1981·Granted Dec 28, 1982·3 cites·4 claims

Join the waitlist — get patent alerts

Get an alert when John Robert Springer files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →